Literature DB >> 35593742

Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening.

Panae Noomuna1,2, John M Hausman1,2, Ruhani Sansoya1, Theodosia Kalfa3,4, Mary Risinger3, Philip S Low1,2.   

Abstract

Although both protein tyrosine phosphatases and kinases are constitutively active in healthy human red blood cells (RBCs), the preponderance of phosphatase activities maintains the membrane proteins in a predominantly unphosphorylated state. We report here that unlike healthy RBCs, proteins in sickle cells are heavily tyrosine phosphorylated, raising the question regarding the mechanism underpinning this tyrosine phosphorylation. Upon investigating possible causes, we observe that protein tyrosine phosphatase 1B (PTP1B), the major erythrocyte tyrosine phosphatase, is largely digested to a lower molecular weight fragment in sickle cells. We further find that the resulting truncated form of PTP1B is significantly less active than its intact counterpart, probably accounting for the intense tyrosine phosphorylation of Band 3 in sickle erythrocytes. Because this tyrosine phosphorylation of Band 3 promotes erythrocyte membrane weakening that causes release of both membrane vesicles and cell free hemoglobin that in turn initiates vaso-occlusive events, we conclude that cleavage of PTP1B could contribute to the symptoms of sickle cell disease. We further posit that methods to inhibit proteolysis of PTP1B could mitigate symptoms of the disease.
© 2022 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  Band 3 tyrosine phosphorylation; PTP1B; calpain proteolysis; cleavage of PTP1B; phosphatase activity; sickle cells

Mesh:

Substances:

Year:  2022        PMID: 35593742      PMCID: PMC9215175          DOI: 10.1096/fj.202100809RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  48 in total

1.  Differential sorting of tyrosine kinases and phosphotyrosine phosphatases acting on band 3 during vesiculation of human erythrocytes.

Authors:  Giampaolo Minetti; Annarita Ciana; Cesare Balduini
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

2.  UVA inactivates protein tyrosine phosphatases by calpain-mediated degradation.

Authors:  Pawan Gulati; Boyka Markova; Martin Göttlicher; Frank-D Böhmer; Peter A Herrlich
Journal:  EMBO Rep       Date:  2004-07-09       Impact factor: 8.807

Review 3.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

4.  Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.

Authors:  P E J Van Der Meijden; M Van Schilfgaarde; R Van Oerle; T Renné; H ten Cate; H M H Spronk
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

5.  Protein Phosphotyrosine Phosphatase 1B (PTP1B) in Calpain-dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (VEGFR2) in Endothelial Cells: IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING.

Authors:  Yixuan Zhang; Qiang Li; Ji Youn Youn; Hua Cai
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

6.  Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets.

Authors:  Shafi M Kuchay; Nayoung Kim; Elizabeth A Grunz; William P Fay; Athar H Chishti
Journal:  Mol Cell Biol       Date:  2007-06-18       Impact factor: 4.272

7.  Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease.

Authors:  Alex George; Suvarnamala Pushkaran; Diamantis G Konstantinidis; Sebastian Koochaki; Punam Malik; Narla Mohandas; Yi Zheng; Clinton H Joiner; Theodosia A Kalfa
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

Review 8.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

9.  Increased tyrosine phosphorylation of band 3 in hemoglobinopathies.

Authors:  H T Terra; M J Saad; C R Carvalho; D L Vicentin; F F Costa; S T Saad
Journal:  Am J Hematol       Date:  1998-07       Impact factor: 10.047

10.  Phosphotyrosine phosphatases acting on band 3 in human erythrocytes of different age: PTP1B processing during cell ageing.

Authors:  Annarita Ciana; Giampaolo Minetti; Cesare Balduini
Journal:  Bioelectrochemistry       Date:  2004-05       Impact factor: 5.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.